Product Information
PAXIL CR 25 MG TABLET is a brand product labeled by Apotex Corp., priced at $10.7983 per EA under NDC 60505437803. Its NADAC has been published 254 times since Mar 17, 2021.
FDA first approved this application on Feb 16, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the paroxetine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/1
Manufacturer
Apotex Corp.NDC
60505437803
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PAROXETINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020936FDA Approved
2/16/1999
TE Code
AB
On Market Since
1/1/2011
Pharmacological Classes
Price Statistics
The NADAC for PAXIL CR 25 MG TABLET has been published 254 times since Mar 17, 2021, and over the history we have for it it has risen 49.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.7983 per EA |
|---|---|
| All-time high | $10.7983 (Sep 30, 2026) |
| All-time low | $7.2474 (Mar 17, 2021) |
| 52-week high | $10.7983 |
| 52-week low | $10.5310 |
| Median price | $9.2268 |
| Average price | $9.1173 |
| Largest weekly change | +9.9% (Sep 4, 2024) |
| Weeks tracked | 254 |
| Tracking since | Mar 17, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
paroxetine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PAXIL CR 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAXIL CR 25 MG TABLET, manufactured by Apotex Corp., is $10.7983 per EA (NDC 60505437803), effective Sep 30, 2026.
How has the price of PAXIL CR 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAXIL CR 25 MG TABLET has risen 49.0%. It has been tracked across 254 weekly CMS publications since Mar 17, 2021.
What are the highest and lowest recorded NADAC prices for PAXIL CR 25 MG TABLET?
Since Mar 17, 2021, the NADAC for PAXIL CR 25 MG TABLET has ranged from a low of $7.2474 (Mar 17, 2021) to a high of $10.7983 (Sep 30, 2026), with a median of $9.2268 per EA.
Are there cheaper alternatives to PAXIL CR 25 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PAROXETINE CR 25 MG TABLET, is $0.3856 per EA — about 96% below PAXIL CR 25 MG TABLET.
Who manufactures PAXIL CR 25 MG TABLET?
PAXIL CR 25 MG TABLET (NDC 60505437803) is labeled by Apotex Corp., and CMS classifies it as a brand product.